348 related articles for article (PubMed ID: 17047085)
1. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.
Wibom C; Mörén L; Aarhus M; Knappskog PM; Lund-Johansen M; Antti H; Bergenheim AT
J Neurooncol; 2009 Sep; 94(3):321-31. PubMed ID: 19350207
[TBL] [Abstract][Full Text] [Related]
4. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of meningiomas.
Cui GQ; Jiao AH; Xiu CM; Wang YB; Sun P; Zhang LM; Li XG
Acta Neurol Belg; 2014 Sep; 114(3):187-94. PubMed ID: 24085542
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin predicts the behaviour of atypical meningioma.
Lin CK; Tsai WC; Lin YC; Hueng DY
Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
[TBL] [Abstract][Full Text] [Related]
9. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
11. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
[TBL] [Abstract][Full Text] [Related]
12. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
Mahzouni P; Movahedipour M
Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
[TBL] [Abstract][Full Text] [Related]
15. Histological classification and molecular genetics of meningiomas.
Riemenschneider MJ; Perry A; Reifenberger G
Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
[TBL] [Abstract][Full Text] [Related]
16. PS6K amplification characterizes a small subset of anaplastic meningiomas.
Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A
Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609
[TBL] [Abstract][Full Text] [Related]
17. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
Myong NH; Chi JG
J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.
Weisberg S; Ashkenazi E; Israel Z; Attia M; Shoshan Y; Umansky F; Brodie C
Am J Pathol; 2001 Oct; 159(4):1193-7. PubMed ID: 11583945
[TBL] [Abstract][Full Text] [Related]
19. The accuracy of meningioma grading: a 10-year retrospective audit.
Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
[TBL] [Abstract][Full Text] [Related]
20. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
